Transparency, especially in the age of social media is vital to increasing confi dence in vaccines.
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The 2018 immunization schedule is available at www.cdc.gov/vaccines/ schedules/hcp/child-adolescent.html. deaths, 20 million cases of disease, and save $13.5 billion in direct health care costs and $68.8 billion in societal costs. Paradoxically, the reduction or elimination of vaccine preventable infections in the United States has been postulated to be a factor associated with an increase in vaccine hesitancy in the 21st century. Parents who have not experienced vaccine-preventable infection may not be able to accurately assess the risk of these infections pose to the health of their children.
The vision of the American Academy of Pediatrics (AAP) Committee on Infectious Diseases (COID)
is to support the optimal health of all children by diminishing the adverse health effects of infectious diseases. Naturally, access to vaccines and vaccine uptake in the United States play large roles in achieving this vision. The COID works in partnership with many organizations to ensure vaccine policies support the health of all children. For example, the COID works closely with the Centers for Disease Control and Prevention (CDC) and has members on all CDC immunization work groups to represent the interests of infants, children, and the pediatric providers who care for them as vaccine policies are developed. This work involves weighing the risks and benefi ts of vaccines and ensuring that the best data are communicated to providers, parents, and others who care for children. To assess among US physicians (1) frequency of requests to spread out recommended vaccination schedule for children ,2 years, (2) attitudes regarding such requests, and (3) strategies used and perceived effectiveness in response to such requests.
Introduction
METHODS: An e-mail and mail survey of a nationally representative sample of pediatricians and family physicians from June 2012 through October 2012.
RESULTS:
The response rate was 66% (534 of 815). In a typical month, 93% reported some parents of children ,2 years requested to spread out vaccines; 21% reported $10% of parents made this request. Most respondents thought these parents were putting their children at risk for disease (87%) and that it was more painful for children (84%), but if they agreed to requests, it would build trust with families (82%); further, they believed that if they did not agree, families might leave their practice (80%). Forty percent reported this issue had decreased their job satisfaction. Most agreed to spread out vaccines when requested, either often/always (37%) or sometimes (37%); 2% would often/always, 4% would sometimes, and 12% would rarely dismiss families from their practice if they wanted to spread out the primary series. Physicians reported using a variety of strategies in response to requests but did not think they were effective.
CONCLUSIONS: Virtually all providers encounter requests to spread out vaccines in a typical month and, despite concerns, most are agreeing to do so. Providers are using many strategies in response but think few are effective. Evidence-based interventions to increase timely immunization are needed to guide primary care and public health practice.
WHAT'S KNOWN ON THIS SUBJECT:
Some parents choose to "spread out" the recommended vaccine schedule for their child by decreasing the number of simultaneous vaccines or delaying certain vaccines until an older age. Epidemiologic studies demonstrate increasing numbers of parents are choosing to delay vaccines.
WHAT THIS STUDY ADDS:
We demonstrate that almost all providers encounter requests to spread out vaccines in a typical month and, despite concerns, increasing numbers are agreeing to do so. Providers report many strategies in response to requests but think few are effective.
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Prevalence of Requests to Spread Out Immunizations and Reasons for Requests
Ninety-three percent of physicians reported some parents of children ,2 years requested spreading out vaccines in a typical month; 21% reported $10% of parents made this request. Compared with the previous year, 23% reported increased, 62% unchanged, and 14% decreased requests. Physicians reported a variety of reasons given by parents requesting to spread out vaccines (Tables 2 and 3) . Almost all reasons given by parents were more commonly reported by pediatricians than family physicians.
Physician Attitudes Regarding Requests
As shown in Fig 1, the vast majority agreed that it was important that all vaccines in the primary series be given on time (92%), that parents who chose to spread out vaccines were putting their children at risk for contracting disease (87%), and that it was more painful for children to bring them back repeatedly for separate injections (84%). The majority also felt that if they agreed to spread out vaccines, it would build trust with families (82%) and that if they did not agree, families might leave their practice (80%). Thirty-five percent thought that if they complied with requests to spread out, they were giving a mixed message to the family, and 40% reported that parental requests to spread out vaccines had decreased their job satisfaction. Compared with family physicians, pediatricians more strongly agreed with most attitudes examined (Fig 1) .
Reported Actions and Strategies Used in Response to Requests
Most physicians reported agreeing to spread out vaccines when requested, either often/always (37%), sometimes (37%), or rarely (26%). Characteristics and attitudes associated with often/always agreeing to spread out in the final multivariable model included pediatric subspecialty, thinking that working with parents regarding the schedule creates a greater degree of trust, and having an understanding of why parents choose to spread out vaccines (see Tables 4 and 5 for bivariable and  multivariable models) . Conversely, practicing in an urban inner-city location, thinking it was important that all vaccines be given at recommended times, or feeling that complying with requests to spread out the series would send a mixed message were negatively associated with the outcome. Pediatricians were more likely than family physicians to dismiss families from their practice if they insisted on spreading out vaccines either often/always (3% vs 1%), sometimes (6% vs 1%), or rarely (14% vs 8%; P , .001), respectively. Table 6 shows strategies used by physicians in response to parental requests to spread out vaccines and their perceived effectiveness in convincing parents to vaccinate their children according to recommended guidelines. Few physicians thought any of the reported responses were "very effective," although many were thought to be "somewhat effective." 
Effects of Requests on Practice

DISCUSSION
In contrast to much of the previous literature regarding parents who refuse all or specific vaccines, the current study focused on the larger group of parents who intend to
FIGURE 1
Physicians' attitudes related to spreading out vaccines in primary series (n = 453). *P , .05 for comparison between specialties (x 2 test) when pediatricians strongly agree more than family medicine physicians. *P , .05 for comparison between specialties (x 2 test) when family medicine physicians strongly agree more than pediatricians.
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SUPPLEMENTAL FIGURE 4
Reverse cumulative distribution plot of overall seroprotection after primary vaccination for each schedule.
SUPPLEMENTAL FIGURE 5
Fold increases in IgG after booster vaccination for each serotype and group. Black-capped bars indicate 95% CI. Comparison of the following: a reduced and accelerated schedules, b accelerated and extended schedules, and c reduced and extended schedules, P < .05. Researchers from the Kaiser Permanente (KP) Vaccine Study Center, Oakland, CA, conducted a retrospective cohort study to determine the effectiveness of tetanus-diphtheria-acellular pertussis (Tdap) vaccination of pregnant women in protecting their infants against pertussis. For the study, medical record data on infants born at KP Northern California hospitals from 2010 to 2015 were reviewed; only infants born at >37 weeks' gestation were included. Vaccine information on mothers of study participants was also abstracted from KP medical records. Mothers were classified as receiving Tdap during pregnancy (>7 days prior to delivery) or not receiving a dose of vaccine during pregnancy. Data on maternal Tdap immunization prior to pregnancy (within 2 years) or after pregnancy (after birth of the study participant) were also collected. Study participants were classified as having pertussis on the basis of a positive polymerase chain reaction finding. The primary study outcome was pertussis in a study infant in the first 2 months after birth, and the main secondary outcome was pertussis in the first year after birth. Cox regression was used to calculate the pertussis hazard ratio (HR) in infants of women vaccinated during pregnancy versus infants of unimmunized women. Vaccine effectiveness (VE) was calculated as 1 -HR. Regression models included potentially confounding variables. Similar analyses were performed to assess the VE for maternal Tdap before or after pregnancy. For the secondary outcome of pertussis in the first year after birth, doses of diphtheria-tetanus-acellular pertussis (DTaP) vaccine in the infant were included in the models.
Tdap Vaccination During Pregnancy
Data on 148,981 infants were included in the analyses; the mothers of 68,168 of these infants received Tdap during pregnancy. There were 17 cases of pertussis in study participants prior to the age of 2 months, including 16 in those whose mothers were not vaccinated (VE, 91.4%; 95% confidence interval [CI], 19.5%-99.1%; P = .032). The estimated VE of maternal Tdap vaccination during pregnancy in preventing pertussis in study infants during the first year after birth was 69.0% (95% CI, 43.6%-82.9%; P < .001). Neither maternal Tdap administered prior to pregnancy or afterward was associated with a decreased risk of pertussis in study infants during the first 2 months after birth (P = .138 and P = .336, respectively).
The researchers conclude that maternal Tdap vaccination is highly protective against infant pertussis, especially in the first 2 months after birth. ]. Thus, the goal of maternal immunization is to provide infants with passive antipertussis antibodies prior to their first dose of DTaP vaccine at 2 months of age. Maternal Tdap demonstrated 91.4% vaccine effectiveness during the first 2 months of the infant's life. During the entire first year, maternal Tdap during pregnancy reduced the infant's pertussis risk by an estimated 69%, after adjustment for the effects of infant DTaP vaccination. In contrast, receipt of Tdap by women in the early postpartum period, "cocooning," was not associated with a decreased risk of pertussis among their infants.
COMMENTARY BY
A second major finding of this study was that maternal Tdap vaccine during pregnancy does not hinder the infant's immune response to the 3-dose primary DTaP series. This finding seems to conflict with the results of a recent meta-analysis by Voysey et al, 4 who used data from clinical trials conducted by a single pharmaceutical company. For acellular pertussis antigens, twofold higher maternal antibody was associated with 11% lower postvaccination antibody for pertussis toxoid and filamentous hemagglutinin. However, the immune correlates of protection are complex and not well defined for these pertussis vaccine antigens. 5 Thus, the clinical relevance in terms of potential reductions in protection against pertussis due to maternal antibody interference with infant vaccine immunogenicity is not known. In contrast, the current investigators demonstrated protection against pertussis disease.
Bottom Line: Maternal Tdap vaccine during pregnancy is safe and protects both the mother and her infant against pertussis.
EDITORS' NOTE
Neither infection nor immunization provide enduring immunity against pertussis. As previously noted, 3 however, the apparent resurgence of pertussis is probably multifactorial. Due in part to waning immunity produced by acellular vaccines that are less reactogenic, but also less immunogenic than their whole-cell counterparts, it reinforces the need for immunization of all pregnant women.
through 2015. Table 1 shows the characteristics of newborns in the study. The mothers of 68 168 infants, 45.8% of the study population, received the Tdap vaccine during pregnancy at least 8 days before birth. Seventeen infants (11.4 per 100 000 infants) in the study population tested positive for pertussis by 2 months of age, and 110 (73.8 per 100 000 infants) tested positive by 1 year of age. Of the 110 pertussis cases in the first year of life, 103 were included in the analyses after censoring criteria for disenrollment were applied.
The unadjusted pertussis incidence was lower in infants whose mothers were vaccinated versus infants whose mothers were not vaccinated during pregnancy. Of the 17 cases in the first 2 months of life, only 1 was a "breakthrough" case where the mother was vaccinated in pregnancy >7 days prior to birth. The unadjusted incidence rate ratio was 0.08 (95% confidence interval [CI], 0.00 to 0.43) for the first 2 months of life and 0.35 (95% CI, 0.21 to 0.55) for the entire first year of life.
Maternal Tdap vaccination during pregnancy reduced pertussis risk by an estimated 91.4% during the first 2 months of life ( Table 2) . During the entire first year of life, maternal Tdap vaccination during pregnancy reduced pertussis risk by an estimated 69.0%, after adjustment for the effects of DTaP vaccination.
Tdap VE for infants who had 0 DTaP doses (from birth through 7 days after the first dose) was estimated at 87.9%; Tdap VE for infants who had protection from 1 DTaP dose (ie, from day 8 after dose 1 through day 7 of dose 2) was an estimated 81.4%; Tdap VE for infants who had protection from 2 DTaP doses, but not yet 3 doses, was an estimated 6.4%; and Tdap VE for infants who had 3 DTaP doses was an estimated 65.9% ( Table 3) . The VE at each DTaP dose was similar in the sensitivity analysis that censored infants who received DTaP at ages older than recommended (results not shown).
Maternal Tdap after pregnancy did not significantly reduce pertussis risk. Pertussis severity in the 17 cases in infants <2 months of age
FIGURE 1
Percentage of infants born in KPNC hospitals whose mother received the Tdap vaccine during pregnancy (at least 8 days before birth) or early postpartum (from the day of birth to 14 days after birth), 2006 to 2015. We include infants whose mothers were continuously enrolled during pregnancy through 14 days postpartum. We exclude the <1% of infants missing data on gestational weeks. Dr Markowitz conceptualized and designed the analyses and drafted the manuscript; Ms Liu conducted the data analyses and reviewed and revised the manuscript; Dr Hariri assisted with study design and data analyses and reviewed and revised the manuscript; Dr Steinau supervised laboratory testing and reviewed and revised the manuscript; Dr Dunne assisted with study design and data collection and reviewed and revised the manuscript; and Dr Unger assisted with study design, supervised laboratory testing, and reviewed and revised the manuscript. All authors approved the fi nal manuscript as submitted.
The fi ndings and conclusions in this report are those of the authors and do not necessarily represent the offi cial position of the Centers for Disease Control and Prevention. 
WHAT'S KNOWN ON THIS SUBJECT:
Recent postmarketing studies in the US have identifi ed a small increased risk of intussusception associated with rotavirus vaccination, mainly in the fi rst week after the fi rst dose. An estimated 1 to 5 excess cases of intussusception occur per every 100 000 children vaccinated.
WHAT THIS STUDY ADDS:
No consistent change in intussusception hospitalization rates was observed among all children <12 months of age but the rate for children 8 to 11 weeks was signifi cantly elevated 46% to 101% in all postvaccine years except 2011 and 2013 compared with prevaccine baseline.
United States. 11 -13 However, given the comparatively low background rate of intussusception in children 8 to 11 weeks of age, no overall increased risk of intussusception was observed among all children <12 months of age, and no consistent change in the rate of intussusception hospitalization was observed in any of the older age groups. 
Angela Myers comments:
Physicians are obligated by oath to "do no harm." 2 Although this obligation sometimes conflicts with other obligations (eg, when we prescribe chemotherapy for a patient with cancer), it is the spirit of this oath that we carry with us every day. In addition, physicians are expected to abstract One of the most divisive issues in pediatrics today concerns the proper response by pediatricians to parents who refuse routine childhood immunizations for their children. Many pediatricians refuse to care for such families. Others continue to provide care and continue to try to convince parents that the benefits of immunizations far outweigh the risks. Two of the most powerful arguments in favor of dismissing such parents are as follows: (1) their refusal suggests such lack of trust in the physicians' recommendations that it undermines the basis for a meaningful physicianpatient-parent relationship; and (2) unimmunized children present an unacceptable risk to other children in the physicians' waiting rooms. This article examines those arguments. T he parents were college-educated and lived in a fairly affl uent suburb. Their fi rst child was 2 months old, and we were discussing immunizations again.
ETHICS ROUNDS
The parents were refusing all vaccines but could not elucidate a cogent reason for their refusal. The baby's grandmother was in the room, too.
I had tried using statistics and science in the fi rst two visits, to no avail. This visit, I decided to put a human face on the issue. After a pause, the grandmother forced a smile and said, "You'd make a good salesman."
I knew I had lost them.
I didn't continue. I didn't even try to tell them I wasn't making a "sale" but was trying to protect their newborn's life.
After scores of similar encounters, the nine providers in our independent, private practice agreed to formulate a policy on how to deal with vaccine refusers. We discussed dismissal as an option for those who absolutely refuse all vaccines. We agreed that if a family didn't trust us on this issue, then the relationship was built on a poor foundation and unlikely to hold up if more complicated medical situations arose. And as a practice with a large number of children with special needs, we didn't want to expose everyone in the waiting room to vaccine-preventable illnesses.
We also were confl icted, since the Academy did not endorse patient dismissal for this reason.
In the end, we decided to dismiss the small minority of patients who we would never convince to get vaccinated. We would work with other vaccine-hesitant parents, such as those who received some but not all recommended vaccines and those who wanted nonstandard schedules.
Our policy states that if the child does not get vaccines required by the state, then they need to fi nd another health care provider.
After that ultimatum, many families who refused or delayed vaccines got the required shots.
But some did not. We dismissed them and offered names of other practitioners they could call.
At fi rst, I felt a little odd telling patients about our policy, although I strongly agreed with it. But after talking with friends and colleagues all over the country, I realized we were part of a trend.
Families who fully vaccinate their children have thanked me for the policy. Those with children who are medically restricted from getting certain vaccines are particularly grateful.
Talking to families about possible dismissal is not easy. But I know it's the right thing to do for the health of all the children in our practice. And I'm glad to fi nally have the Academy's support.
about autism (which declined between survey years). In both 2006 and 2013, pediatricians reported that they were able to convince approximately 30% of parents to vaccinate their children when they initially refused. Another observational study found that when physicians continued to engage parents, up to 47% of parents ultimately accepted vaccines after initially refusing them. 9 Although the majority of parents accept vaccines, the increasing frequency of refusal and the requests for alternative vaccine schedules indicate that there are still significant barriers to overcome. 10
TERMINOLOGY
The term vaccine hesitancy has emerged to depolarize the "pro" versus "anti" vaccination alignment and to express the spectrum of parental attitudes toward vaccines. 1 
VACCINES ARE TESTED THOROUGHLY
Vaccine development is a long and arduous process, often lasting many years and involving a combination of public and private partnerships. The current system for developing, testing, and regulating vaccines requires that the vaccines demonstrate both safety and efficacy before licensure and that long-term safety is monitored (http:// www. historyofvaccines . org/ content/ articles/ vaccine-developmenttesting-and-regulation; Fig 1) . The first step in vaccine discovery involves the identification of a need for a vaccine and an understanding of the mechanism of protective immunity against that disease. or polio, and less relevant to, for example, vaccines against human papillomavirus (HPV), for which the benefits of immunization in preventing cancer may take years or decades to become apparent. Figure  2 clearly highlights the delicate balance between perceived risk and benefit for each vaccine and how this balance is linked integrally to vaccine acceptance.
PARENTS' VARIED CONCERNS ABOUT VACCINES SHOULD BE ADDRESSED
A number of studies have attempted to define the reasons why parents are vaccine hesitant, and these factors are summarized in Table 2 . 1, 4, 5, 15, 43 -45 In 1 study, 44% of parents reported concern over pain associated with receiving multiple injections during a single visit, 34% expressed unease about receiving too many vaccines at a single visit, 26% worried about the development of autism or other potential learning difficulties after receiving vaccines, 13.5% expressed concern that vaccines could lead to chronic illnesses, and 13.2% stated that vaccines were not tested enough for safety before their use. 45 Concerns about vaccine safety and questions about the necessity of vaccines are often cited as reasons for vaccine refusal. 43, 46 -48 One survey found that parents who decide to not vaccinate their children have a greater distrust of health care professionals and the government and are more likely to use complementary and alternative medicine, compared with parents who vaccinate their children. 47 Freed et al 43 also conducted an online survey of several thousand parents to identify vaccine concerns. Most of the surveyed parents agreed that vaccines protected their children from diseases; however, more than half expressed concerns regarding serious adverse effects of vaccines. Overall, 11.5% of parents in that study had refused at least 1 recommended vaccine, and the fear that vaccines could cause autism was often cited as a reason for refusal. 43 Parental concerns must be addressed, and concerns will vary among parents. For example, vaccine safety and triggering early sexual activity are often cited as parental concerns about the HPV vaccine. 49 Reassuring parents that the vaccine is safe and that there is no evidence that HPV vaccine increases sexual activity may dispel their concerns. 50 Some parents are concerned primarily about the pain associated with immunizations. Strategies to reduce pain include administering vaccines quickly without aspirating, holding the child upright, administering the most painful vaccine last, and 
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abstract Routine childhood immunizations against infectious diseases are an integral part of our public health infrastructure. They provide direct protection to the immunized individual and indirect protection to children and adults unable to be immunized via the effect of community immunity. All 50 states, the District of Columbia, and Puerto Rico have regulations requiring proof of immunization for child care and school attendance as a public health strategy to protect children in these settings and to secondarily serve as a mechanism to promote timely immunization of children by their caregivers. Although all states and the District of Columbia have mechanisms to exempt school attendees from specifi c immunization requirements for medical reasons, the majority also have a heterogeneous collection of regulations and laws that allow nonmedical exemptions from childhood immunizations otherwise required for child care and school attendance. The American Academy of Pediatrics (AAP) supports regulations and laws requiring certifi cation of immunization to attend child care and school as a sound means of providing a safe environment for attendees and employees of these settings. The AAP also supports medically indicated exemptions to specifi c immunizations as determined for each individual child. The AAP views nonmedical exemptions to school-required immunizations as inappropriate for individual, public health, and ethical reasons and advocates for their elimination.
BACKGROUND
Principles of Childhood Immunization and Community Immunity
Childhood immunization is one of the greatest accomplishments of modern medicine. The evaluators found no significant difference in either outcome between the 2 groups.
The study raises questions about whether either approach is effective in improving immunization coverage. The outcome suggests that immunization delivery is a complex process and neither QI through web-based education nor pay-for-performance is a complete answer to reaching that 2020 goal of 90% immunization coverage. We also assessed immunization up-to-date (UTD) status.
RESULTS: Data were analyzed from 3, 147 patient records from 32 practices. Practices in the study arms reported similar QI activities (∼6 to 7 activities). We found no difference in PANVR between P4P and QITS (mean ± SE, 90.7% ± 1.1% vs 86.1% ± 1.3%, P = 0.46). Likewise, there was no difference in odds of being UTD between study arms (adjusted odds ratio 1.02, 95% confidence interval 0.68 to 1.52, P = .93). In within-group analysis, patients in both arms experienced nonsignificant increases in PANVR. Similarly, the change in adjusted odds of UTD over time was modest and nonsignificant for P4P but reached significance in the QITS arm (adjusted odds ratio 1.28, 95% confidence interval 1.02 to 1.60, P = .03).
CONCLUSIONS: Participation in either a financial incentives program or a virtual learning collaborative led to self-reported improvements in immunization practices but minimal change in objectively measured immunization coverage. Dr Fu conceptualized the design of the study, supervised recruitment and data collection, and participated in data acquisition, analysis, and interpretation, and helped draft the initial manuscript; Ms Zook and Drs Gingold and Briccetti performed participant enrollment, participated in the design of the data collection instruments, and performed data collection and initial data analysis; Dr Gillespie contributed to the design of the study and performed all fi nal data analysis; Drs Cora-Bramble, Joseph, and Moon contributed to the design of the study; Ms Haimowitz helped draft the initial manuscript; and all authors critically reviewed and revised the manuscript and approved the fi nal version as submitted. During the 1950s, Solomon Asch conducted seminal studies of the impact of social influence on judgment. In one set of experiments, several groups were asked to match the length of 3 lines drawn on a piece a paper to a standard line drawn on another paper. 4 Only 1 of the 3 lines was equal to the standard. Before the experiment, all but 1 person in each group, the critical subject, were covertly told to vocally and unanimously express the wrong judgment about which line matched the standard. The results were striking. Compared with subjects who were part of control groups in which no artificial majority was created, critical subjects were much less likely to match the correct line to the standard (95% vs 24%, respectively): their judgements were distorted by the unanimously wrong majority. When interviewed afterward, subjects most likely to agree with the majority were less confident of their rightness, more doubtful, and felt more temptation to conform.
The pressure to conform to group opinion is relevant to immunization decision-making. In a survey study, Hershey and colleagues found that among 3 factors hypothesized to be involved in immunization decisions: altruism, free-riding, and bandwagoning (ie, doing what most other people do), bandwagoning had the greatest effect on vaccine acceptance. 5 Similarly, as part of an international ethnographic study, Streefland and colleagues observed a collective dimension to decisionmaking: "people have their children vaccinated because everybody does and it seems the normal thing to do." 6 Brunson continues this inquiry into the impact of social influence by exploring the features inherent to the social groups of parents who do and do not conform to the recommended vaccination schedule. Her results lay bare a fundamental question: are social networks a window or mirror into parental immunization decisions? That is, does the collective advice from a parent' s social network serve as an opportunity to explore diverse ideas and viewpoints about immunization and specific vaccines, or does it simply reflect and reinforce what that parent is already predisposed to think and do?
surveys' findings with other published findings and feedback from an expert panel of pediatricians, family physicians, other vaccine providers, and researchers. These experts did not practice at our pilot or trial clinics. In April 2015, we piloted our trainings in 2 clinics, conducted follow-up phone calls with 3 of the clinics' vaccine-prescribing clinicians to gather additional feedback, reviewed posttraining satisfaction surveys, and refined the trainings.
Training Content
The announcement training, informed by the work of Opel and colleagues, 16, 17 included the steps shown in Fig 2A. The darker boxes indicate requisite steps for delivering announcements, whereas lighter boxes are necessary only if the previous step did not result in HPV vaccination. We instructed providers to first announce that the child is due for 3 vaccines to be given today. Key elements of this first step included providers mentioning the child's age; announcing the child is due for 3 vaccines recommended for children this age, placing HPV vaccine in the middle of list; and saying they will vaccinate today (Supplemental Fig 3) . Only if parents raised a concern would providers then identify and ease parents' main concern about HPV vaccine, using a structured approach 20 and strongly recommending same-day HPV vaccination. Key elements of this final step included providers giving a motivational statement, ending with the phrase "I recommend …" and encouraging parents to get HPV vaccine that day (Supplemental Fig 3) .
In contrast, the conversation training built on the principles of shared decision making. It differed from the announcement training primarily in the first step. We instructed providers to first start the conversation about 3 adolescent vaccines. Key elements of this first step included providers introducing the 3 vaccines recommended for children this age, placing HPV vaccine in the middle of the list to deemphasize it and make it routine, 21 discussing the health benefits of these vaccines, and inviting parents' questions while saving the recommendation for later in the conversation ( Fig 2B) .
For both trainings, we provided general advice on addressing common problems posed by HPV vaccine communication. For instance, if parents associated the vaccine with sex, we suggested providers redirect the conversation to be about cancer prevention. If parents asked which vaccines are required for school attendance and which are optional, we suggested providers redirect the conversation by saying they strongly recommend all 3 adolescent vaccines.
FIGURE 1
Trial fl ow diagram. QI, quality improvement; vax, vaccine.
INTRODUCTION
Immunization is a key preventive cornerstone of pediatric care. 1 Current data show a need for improvement in adolescent immunization rates. 2 Healthy People 2020 lists 3 adolescent health indicators, which focus on the proportion of adolescents who have (1) well visits, (2) medical insurance, and (3) vaccination coverage. 3 Unfortunately, there is a notable downward trend in health care utilization from childhood to early adulthood. One study found that the overall rate for any health care utilization was 88%, 83%, and 72% for 0-through 11-year-olds, 12-through 17-year-olds, and 18-through 25-year-olds, respectively. 4 Another study documented that early adolescents (11 through 14 years of age) had 3 times more preventive visits than late adolescents. 5 Without 
Overcoming Vaccine Hesitancy
Vaccine hesitancy in adolescent health care can be challenging to address. 14 The AAP has recently published a clinical report that provides information for pediatricians to address vaccinehesitant parents. 14 The following are important approaches that providers should use to increase vaccination rates: 
